As of 2024-12-12, the Fair Value of Athira Pharma Inc (ATHA) is -14.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.62 USD, the upside of Athira Pharma Inc is -2,385.52%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -5.16 | -19.96 | -54.85 | -95.64 | -117.67 | -58.66 |
| YoY growth | -1.18% | -286.82% | -174.80% | -74.37% | -23.04% | -112.04% |
| Market Cap (mil) | 23.89 |
| P/E | |
| Forward P/E |
| EPS | -2.84 |
| Avg earnings growth rate | -112.04% |
| TTM earnings | -109.22 |